Wikidata

(Q52869619)

English

Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.

scientific article published on 17 February 2015

In more languages

Statements

title
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25691671
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691671%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q52869619&oldid=1743872703"